Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer ...Middle East

Medscape - News
Hormone therapy did not increase mortality in postmenopausal women treated for early-stage estrogen receptor–positive breast cancer, but there was a recurrence risk with vaginal estrogen therapy. MDedge News

Hence then, the article about hormone therapy risk in postmenopausal er breast cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer )

Apple Storegoogle play

Last updated :

Also on site :